A rating of 45 puts I-Mab ADR (IMAB) near the middle of the Biotechnology industry according to InvestorsObserver. I-Mab ADR's score of 45 means it scores higher than 45% of stocks in the industry. I-Mab ADR also received an overall rating of 46, putting it above 46% of all stocks. Biotechnology is ranked 31 out of the 148 industries.
IMAB has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on IMAB!